Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Caffeine and adenosine.

Ribeiro JA, Sebastião AM.

J Alzheimers Dis. 2010;20 Suppl 1:S3-15. doi: 10.3233/JAD-2010-1379. Review.

PMID:
20164566
2.

Adenosine receptors and the central nervous system.

Sebastião AM, Ribeiro JA.

Handb Exp Pharmacol. 2009;(193):471-534. doi: 10.1007/978-3-540-89615-9_16. Review.

PMID:
19639292
3.

Adenosine receptors in the nervous system: pathophysiological implications.

Ribeiro JA, Sebastião AM, de Mendonça A.

Prog Neurobiol. 2002 Dec;68(6):377-92. Review.

PMID:
12576292
4.

Caffeine, adenosine receptors, and synaptic plasticity.

Costenla AR, Cunha RA, de Mendonça A.

J Alzheimers Dis. 2010;20 Suppl 1:S25-34. doi: 10.3233/JAD-2010-091384. Review.

PMID:
20182030
5.

Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies.

Takahashi RN, Pamplona FA, Prediger RD.

Front Biosci. 2008 Jan 1;13:2614-32. Review.

PMID:
17981738
6.

Adenosine receptor control of cognition in normal and disease.

Chen JF.

Int Rev Neurobiol. 2014;119:257-307. doi: 10.1016/B978-0-12-801022-8.00012-X. Review.

PMID:
25175970
7.

Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies.

Chen JF, Chern Y.

Handb Exp Pharmacol. 2011;(200):267-310. doi: 10.1007/978-3-642-13443-2_10. Review.

PMID:
20859800
8.

Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects.

Nehlig A, Daval JL, Debry G.

Brain Res Brain Res Rev. 1992 May-Aug;17(2):139-70. Review.

PMID:
1356551
9.

Functions of neuronal adenosine receptors.

Haas HL, Selbach O.

Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):375-81. Review.

PMID:
11111831
10.

Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine.

Fredholm BB.

Pharmacol Toxicol. 1995 Feb;76(2):93-101. Review.

PMID:
7746802
11.

Adenosine A2 receptor-mediated excitatory actions on the nervous system.

Sebastião AM, Ribeiro JA.

Prog Neurobiol. 1996 Feb;48(3):167-89. Review.

PMID:
8735876
12.

Pharmacological rationale for the clinical use of caffeine.

Sawynok J.

Drugs. 1995 Jan;49(1):37-50. Review.

PMID:
7705215
13.

[Perspectives on the therapy of neuropsychiatric diseases with adenosinergic substances].

Erfurth A, Schmauss M.

Fortschr Neurol Psychiatr. 1995 Mar;63(3):93-8. Review. German.

PMID:
7759049
14.

Participation of adenosine receptors in neuroprotection.

Ribeiro JA, Sebastiao AM, de Mendonca A.

Drug News Perspect. 2003 Mar;16(2):80-6. Review.

PMID:
12792668
15.

Adenosine receptors and neurological disease: neuroprotection and neurodegeneration.

Stone TW, Ceruti S, Abbracchio MP.

Handb Exp Pharmacol. 2009;(193):535-87. doi: 10.1007/978-3-540-89615-9_17. Review.

PMID:
19639293
16.

Alkylxanthines as research tools.

Daly JW.

J Auton Nerv Syst. 2000 Jul 3;81(1-3):44-52. Review.

PMID:
10869699
17.

Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline.

Cunha RA, Agostinho PM.

J Alzheimers Dis. 2010;20 Suppl 1:S95-116. doi: 10.3233/JAD-2010-1408. Review.

PMID:
20182043
18.

What knock-out animals tell us about the effects of caffeine.

Chen JF, Yu L, Shen HY, He JC, Wang X, Zheng R.

J Alzheimers Dis. 2010;20 Suppl 1:S17-24. doi: 10.3233/JAD-2010-1403. Review.

PMID:
20182058
19.

Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation.

Chen JF, Sonsalla PK, Pedata F, Melani A, Domenici MR, Popoli P, Geiger J, Lopes LV, de Mendonça A.

Prog Neurobiol. 2007 Dec;83(5):310-31. Epub 2007 Sep 29. Review.

PMID:
18023959
20.

Behavioral and physiological effects of xanthines in nonhuman primates.

Howell LL, Coffin VL, Spealman RD.

Psychopharmacology (Berl). 1997 Jan;129(1):1-14. Review.

PMID:
9122357

Supplemental Content

Support Center